middle.news
Argent BioPharma unlocks global cannabis genetics deal with Thai partner
8:19am on Tuesday 27th of October, 2026 AEDT
•
Biotechnology and Pharmaceuticals
Read Story
Argent BioPharma unlocks global cannabis genetics deal with Thai partner
8:19am on Tuesday 27th of October, 2026 AEDT
Key Points
10-year exclusive worldwide licence to Thai Phytomed International
Four proprietary cannabis genotypes covered
Argent retains ownership of the genetics and related intellectual property
15% royalty on profits from commercialisation and permitted sublicensing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Argent Biopharma (ASX:RGT)
OPEN ARTICLE